These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25650732)

  • 21. Serum IGF-I, IGFBP-3 and ALS concentrations and physical performance in young swimmers during a training season.
    Tourinho Filho H; Pires M; Puggina EF; Papoti M; Barbieri R; Martinelli CE
    Growth Horm IGF Res; 2017 Feb; 32():49-54. PubMed ID: 28011098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of endurance training on insulin-like growth factor-1 in older individuals.
    Poehlman ET; Rosen CJ; Copeland KC
    Metabolism; 1994 Nov; 43(11):1401-5. PubMed ID: 7526125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance?
    Eriksson J; Tuominen J; Valle T; Sundberg S; Sovijärvi A; Lindholm H; Tuomilehto J; Koivisto V
    Horm Metab Res; 1998 Jan; 30(1):37-41. PubMed ID: 9503037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes.
    Nguyen UN; Mougin F; Simon-Rigaud ML; Rouillon JD; Marguet P; Regnard J
    Eur J Appl Physiol Occup Physiol; 1998 Nov; 78(6):533-7. PubMed ID: 9840408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical capacity influences the response of insulin-like growth factor and its binding proteins to training.
    Rosendal L; Langberg H; Flyvbjerg A; Frystyk J; Ørskov H; Kjaer M
    J Appl Physiol (1985); 2002 Nov; 93(5):1669-75. PubMed ID: 12381752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential basal and exercise-induced IGF-I system responses to resistance vs. calisthenic-based military readiness training programs.
    Nindl BC; Alemany JA; Rarick KR; Eagle SR; Darnell ME; Allison KF; Harman EA
    Growth Horm IGF Res; 2017 Feb; 32():33-40. PubMed ID: 27979730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of aerobic exercise on insulin, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in overweight and obese postmenopausal women.
    Wieczorek-Baranowska A; Nowak A; Michalak E; Karolkiewicz J; Pospieszna B; Rutkowski R; Laurentowska M; Pilaczyńska-Szcześniak L
    J Sports Med Phys Fitness; 2011 Sep; 51(3):525-32. PubMed ID: 21904293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detraining and tapering effects on hormonal responses and strength performance.
    Izquierdo M; Ibañez J; González-Badillo JJ; Ratamess NA; Kraemer WJ; Häkkinen K; Bonnabau H; Granados C; French DN; Gorostiaga EM
    J Strength Cond Res; 2007 Aug; 21(3):768-75. PubMed ID: 17685721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
    Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose.
    Clemmons DR; Moses AC; Sommer A; Jacobson W; Rogol AD; Sleevi MR; Allan G
    Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D; Schulze MB; Boeing H; Pischon T
    Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training.
    Roelen CA; de Vries WR; Koppeschaar HP; Vervoorn C; Thijssen JH; Blankenstein MA
    Int J Sports Med; 1997 May; 18(4):238-41. PubMed ID: 9231837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of programmed exercise on insulin sensitivity in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Bueno-Notivol J; Calvo-Latorre J; Alonso-Ventura V; Pasupuleti V; Hernandez AV; Pérez-López FR;
    Menopause; 2017 Dec; 24(12):1404-1413. PubMed ID: 28654627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30-50-year-old women.
    Schmitz KH; Ahmed RL; Yee D
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1597-604. PubMed ID: 12496050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of exercise on insulin-like growth factor-I, insulin, and glucose in young women participating in a 16-week randomized controlled trial.
    Arikawa AY; Kurzer MS; Thomas W; Schmitz KH
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2987-90. PubMed ID: 20833973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.